These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15073132)

  • 1. Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.
    Neville K; Parise RA; Thompson P; Aleksic A; Egorin MJ; Balis FM; McGuffey L; McCully C; Berg SL; Blaney SM
    Clin Cancer Res; 2004 Apr; 10(7):2525-9. PubMed ID: 15073132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates.
    Renbarger J; Aleksic A; McGuffey L; Dauser R; Berg S; Blaney S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):39-42. PubMed ID: 14551735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and disposition of imatinib mesylate in healthy volunteers.
    Gschwind HP; Pfaar U; Waldmeier F; Zollinger M; Sayer C; Zbinden P; Hayes M; Pokorny R; Seiberling M; Ben-Am M; Peng B; Gross G
    Drug Metab Dispos; 2005 Oct; 33(10):1503-12. PubMed ID: 16006570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates.
    Kerr JZ; Berg SL; Dauser R; Nuchtern J; Egorin MJ; McGuffey L; Aleksic A; Blaney S
    Cancer Chemother Pharmacol; 2001 May; 47(5):411-4. PubMed ID: 11391856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations.
    Schleyer E; Pursche S; Köhne CH; Schuler U; Renner U; Gschaidmeier H; Freiberg-Richter J; Leopold T; Jenke A; Bonin M; Bergemann T; le Coutre P; Gruner M; Bornhäuser M; Ottmann OG; Ehninger G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):23-36. PubMed ID: 14659433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid.
    Takayama N; Sato N; O'Brien SG; Ikeda Y; Okamoto S
    Br J Haematol; 2002 Oct; 119(1):106-8. PubMed ID: 12358909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.
    Kim A; McCully C; Cruz R; Cole DE; Fox E; Balis FM; Widemann BC
    Invest New Drugs; 2012 Apr; 30(2):524-8. PubMed ID: 21072558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics and CYP3A12-dependent metabolism of c-kit inhibitor imatinib in dogs.
    Ishizuka M; Nagai S; Sakamoto KQ; Fujita S
    Xenobiotica; 2007 May; 37(5):503-13. PubMed ID: 17523053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate.
    Riva L; Blaney SM; Dauser R; Nuchtern JG; Durfee J; McGuffey L; Berg SL
    Clin Cancer Res; 2000 Mar; 6(3):994-7. PubMed ID: 10741726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia.
    Golabchifar AA; Rezaee S; Ghavamzadeh A; Alimoghaddam K; Dinan NM; Rouini MR
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):85-93. PubMed ID: 24817601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing.
    Mueller BU; Anderson BD; Farley MQ; Murphy R; Zuckerman J; Jarosinski P; Godwin K; McCully CL; Mitsuya H; Pizzo PA; Balis FM
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1815-8. PubMed ID: 9661027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Titier K; Picard S; Ducint D; Teilhet E; Moore N; Berthaud P; Mahon FX; Molimard M
    Ther Drug Monit; 2005 Oct; 27(5):634-40. PubMed ID: 16175138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.
    Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG
    Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry.
    Bakhtiar R; Khemani L; Hayes M; Bedman T; Tse F
    J Pharm Biomed Anal; 2002 Jun; 28(6):1183-94. PubMed ID: 12049982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.
    Parise RA; Ramanathan RK; Hayes MJ; Egorin MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):39-44. PubMed ID: 12798163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates.
    Berg SL; Stone J; Xiao JJ; Chan KK; Nuchtern J; Dauser R; McGuffey L; Thompson P; Blaney SM
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):85-8. PubMed ID: 15042312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
    Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
    J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low concentrations of STI571 in the cerebrospinal fluid: a case report.
    Petzer AL; Gunsilius E; Hayes M; Stockhammer G; Duba HC; Schneller F; Grünewald K; Poewe W; Gastl G
    Br J Haematol; 2002 Jun; 117(3):623-5. PubMed ID: 12028032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.